MEDIUM confidence
Researched 2026-08-04 20:43 · profile: researcher
Programme Thesis
The ASCPT LMIC Accelerator Program funds scholars and scientists from low-to-middle-income countries to participate in ASCPT's global network of clinical pharmacologists and translational scientists, through quarterly virtual events and the ASCPT Annual Meeting. It exists to promote diversity, equity, and inclusion in global health forums and foster cross-sector collaboration.
Selection Criteria
- Applicant must be from a low-to-middle-income country (LMIC) as defined by the World Bank.
- Demonstrated interest and activity in clinical pharmacology or translational science.
- Potential to benefit from and contribute to ASCPT's network and annual meeting.
- Likelihood of active participation in quarterly virtual events and the in-person Annual Meeting.
- Quality of application materials, including a clear statement of purpose and alignment with ASCPT's mission.
Past Winners / Cohort Profiles
Past cohorts typically include early-career researchers, clinicians, and scientists from LMICs who are actively engaged in clinical pharmacology or translational research. They often have a track record of local research or clinical practice and seek international exposure and collaboration. Named examples are not listed on the page, but the program emphasizes diversity and inclusion, so winners likely represent a range of countries and research areas.
Ideal Candidate Fingerprint
The ideal applicant is an early-career clinical pharmacologist or translational scientist from an LMIC with a clear research or practice focus, who can articulate how ASCPT membership and the Annual Meeting will accelerate their work and who will actively engage with the global community. They should have a strong local track record and a collaborative mindset.
Recommended Framing
For Eniola, the strongest angle is to frame his independent research in computational pharmacology—specifically the CCT model and neurocascade—as a translational science effort that bridges clinical pharmacology and digital health, directly addressing addiction and drug safety in LMIC contexts like Nigeria. His pharmacist license and ongoing M.Sc. in Digital Health position him as a bridge between traditional clinical pharmacology and modern computational methods, which aligns with ASCPT's mission to advance clinical pharmacology for patients and society globally. He should emphasize how ASCPT's network and annual meeting would enable him to validate and disseminate his models to a global audience, and how his LMIC perspective enriches the field.
Watch Out
None identified. The applicant is a Nigerian national (LMIC), early-career, and has a pharmacy degree and research in clinical pharmacology, which meets the core eligibility. However, the program is a travel grant/accelerator, not a research grant, so the applicant should ensure they frame their work as clinical pharmacology/translational science rather than pure computational biology or software engineering.